OM:MCAPLife Sciences
MedCap (OM:MCAP) Stock EPS Growth Supports Bullish Profit Narrative After Q2 2026 Results
MedCap (OM:MCAP) has put solid numbers on the board for Q2 2026, reporting revenue of SEK619.3 million and basic EPS of SEK4.61, with trailing 12 month EPS at SEK16.07 supported by net income of SEK240.6 million on SEK2.27 billion of revenue. The company has seen revenue move from SEK1.84 billion to SEK2.27 billion over the trailing 12 month period, while basic EPS over the same span has shifted from SEK13.59 to SEK16.07. This gives investors a clear line of sight on how earnings and the top...